[Yingli Green Energy Reports Second Quarter 2011 Results STYLE="font-family:Times New Roman" SIZE="2"> Quarterly Shipmentreased by 36.6% to Reach a Historical High Diluted EPS Was US$0.36 BAODING, China, August19, 2011 Second Quarter 2011nsolidated Financial and Operating Highlights Total net revenuesreased by 27.4% to RMB 4,398.8million (US$680.6 million) from the first quarter of 2011.]
[FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): August 19, 2011 CHINA SHENGDA PACKAGING GROUP INC Nevada 333-168307 26-1559574 (State or other jurisdiction of (IRS Employer Identification No.) incorporation or organization) No. 2 Beitang Road Xiaoshan Economic and Technological Development Zone Hangzhou, Zhejiang Province 311215 People's Republic of China (86) 571-82838805 _______________________________________________ see [ ] []
[Tianyin Pharmaceutical Co., Inc. NYSE Amex: TPI rd 23 August 22, 2011 Division of Corporate Finance 100 F. Street, N.E. Attn: Mr. Frank Wyman Re: Tianyin Pharmaceutical Co., Inc. Form 10-K for the Fiscal Year Ended June 30, 2010 File No. 001-34189 Dear Mr. Wyman: This letter is provided in response to your letter dated June 10, 2011 regarding the]
[SKYSTAR BIO-PHARMACEUTICALMPANY FORM10-Q INDEX Page No. 3 PART I.FINANCIAL INFORMATION 4 Item 1.ndensednsolidated Financial Statements 4ndensednsolidated Balance Sheets of June 30, 2011 (unaudited) and December 31, 2010 4ndensednsolidated Statements ofome and Othermprehensiveomefor the Six Months Ended June 30, 2011 and 2010 (unaudited)] [CERTIFICATION I, WeibingLu, certify that: 1. I have reviewed this quarterly report on Form 10-Q ofYSTARBIO-PHARMACEUTICALCOMPANY; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Bing Mei, certify that: 1. I have reviewed this quarterly report on Form 10-Q ofYSTARBIO-PHARMACEUTICALCOMPANY; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. WeibingLu v233000_ex32-1.htm 4 EX-32.1] [CERTIFICATION (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. Bing Mei Bing Mei Chief Financial Officer (Principal Accounting and Financial Officer) v233000_ex32-2.htm 5 EX-32.2]
[FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): August 19, 2011 CHINA SHENGDA PACKAGING GROUP INC Nevada 333-168307 26-1559574 (State or other jurisdiction of (IRS Employer Identification No.) incorporation or organization) No. 2 Beitang Road Xiaoshan Economic and Technological Development Zone Hangzhou, Zhejiang Province 311215 People's Republic of China (86) 571-82838805 _______________________________________________ see [ ] []
[Tianyin Pharmaceutical Co., Inc. NYSE Amex: TPI rd 23 August 22, 2011 Division of Corporate Finance 100 F. Street, N.E. Attn: Mr. Frank Wyman Re: Tianyin Pharmaceutical Co., Inc. Form 10-K for the Fiscal Year Ended June 30, 2010 File No. 001-34189 Dear Mr. Wyman: This letter is provided in response to your letter dated June 10, 2011 regarding the]
[SKYSTAR BIO-PHARMACEUTICALMPANY FORM10-Q INDEX Page No. 3 PART I.FINANCIAL INFORMATION 4 Item 1.ndensednsolidated Financial Statements 4ndensednsolidated Balance Sheets of June 30, 2011 (unaudited) and December 31, 2010 4ndensednsolidated Statements ofome and Othermprehensiveomefor the Six Months Ended June 30, 2011 and 2010 (unaudited)] [CERTIFICATION I, WeibingLu, certify that: 1. I have reviewed this quarterly report on Form 10-Q ofYSTARBIO-PHARMACEUTICALCOMPANY; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Bing Mei, certify that: 1. I have reviewed this quarterly report on Form 10-Q ofYSTARBIO-PHARMACEUTICALCOMPANY; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. WeibingLu v233000_ex32-1.htm 4 EX-32.1] [CERTIFICATION (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. Bing Mei Bing Mei Chief Financial Officer (Principal Accounting and Financial Officer) v233000_ex32-2.htm 5 EX-32.2]
[Perfect World Co., Ltd. Kelvin Wing Kee Lau Chief Financial Officer 2 Page]
[FORM 10-Q/A (Amendment No. 1) (Mark One) For the quarterly period ended March 31, 2011 For the transition period from _______________ to _______________ Tianyin Pharmaceutical Co., Inc. Delaware (State or other jurisdiction of incorporation or organization) 23rd Floor, Unionsun Yangkuo Plaza No. 2, Block 3, Renmin Road South Chengdu, P. R. China, 610041 +0086-028-86154737 (Address, including zip code, and telephone] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER I, Guoqing Jiang certify that: 1. I have reviewed this quarterly report on Form 10-Q/A of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [CERTIFICATION OF CHIEF FINANCIAL OFFICER I, James Jiayuan Tong, certify that: 1. I have reviewed this quarterly report on Form 10-Q/A of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Guoqing Jiang Chief Executive Officer & Chairman] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. James Jiayuan Tong James Jiayuan Tong Chief Financial Officer, Chief Accounting Officer, Chief Business and Development Officer,]
[UTStarcom Announcesmpany Stock Repurchase Program of Up to $20 Million and Management Stock Repurchase Program of Up to $0.5 Million BEIJING, CHINA August15, 2011 UTStarcomsrp. (UTStarcom or thempany) (Nasdaq: UTSI) a leading provider of interactive,IP-based network solutions in iDTV,IPTV,Internet TV and Broadband forble and telecom operators today announced that its board of directors has approved]
